companies · BE EditionLive
Amyl Therapeutics
Amyl TherapeuticsLocation
Region
flanders
Founded
2020
Status
active
Website
Sector
biotech, medtech, deeptech
TLDR
Amyl Therapeutics is a preclinical-stage biotechnology company developing Pan-Amyloid Immunotherapy for neurodegenerative diseases.
Overview
Amyl Therapeutics develops Pan-Amyloid Immunotherapy, described as a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases like Alzheimer's and Parkinson's. The therapy is designed to target toxic amyloid species and act at every stage of disease progression.
See also
LocationLeuven
Filed under